| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1996) |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| ATC: | L03AX13 |
| UNII: | 5M691HL4BO |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 3 | D020529 | ClinicalTrials |
| Glaucoma, Angle-Closure | 3 | D015812 | ClinicalTrials |
| Optic Neuritis | 3 | D009902 | ClinicalTrials |
| Crohn Disease | 2 | D003424 | ClinicalTrials |
| Rett Syndrome | 2 | D015518 | ClinicalTrials |
| Multiple Sclerosis, Chronic Progressive | 2 | D020528 | ClinicalTrials |
| Multiple Sclerosis, Chronic Progressive | 2 | D020528 | ClinicalTrials |
| Macular Degeneration | 2 | D008268 | ClinicalTrials |
| Amyotrophic Lateral Sclerosis | 2 | D000690 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL1201507 |
| FDA SRS | 5M691HL4BO |
CONTENTS